Kamada (KMDA) Posts Q1 Loss of 15c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St set for muted open as Middle East tensions curb risk appetite
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Kamada Reports First Quarter 2015 Financial Results
May 12, 2015 7:00 AM EDTIntroduces 2015 Revenue Guidance
Conference call begins today at 8:30 a.m. Eastern time
NESS ZIONA, Israel--(BUSINESS WIRE)-- Kamada Ltd. (NASDAQ: KMDA) (TASE: KMDA), a plasma-derived protein therapeutics company focused on orphan indications, announces financial results for the three months ended March 31, 2015.
Financial highlights of the 2015 first quarter included:
Total revenues of $9.0 million compared with $13.2 million for the first quarter of 2014; Gross profit of $0.4 million compared with $3.3 million in the year-ago first quarter;... More